News
5h
Zacks.com on MSNIs Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...
1h
Stocktwits on MSNEli Lilly Stock Gets A Double Downgrade And Price Target Cut By HSBC Over Valuation, Competition ConcernsHSBC on Monday double downgraded Eli Lilly and Co. (LLY) stock to ‘Reduce’ from ‘Buy’ and also lowered its price target to ...
We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.
Tariff wars and macro woes have impacted investor sentiment, weighing on stocks across various sectors. However, healthcare ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Weight loss drugs like Ozempic, Zepbound and Wegovy are surging in popularity. Now, a new pill from Eli Lilly has taken a ...
Bamlanivimab and etesevimab combination has been authorised under Emergency Use Authorisation in the US and select EU countries for the treatment of the disease.
We are on campus with a select team of staff to assist students and the University community while also continuing to provide services remotely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results